Action mechanism and signal pathways of psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells

Kuan Chou Chen, Chiung Chi Peng, Wen Ta Chiu, Yu Ting Cheng, Guan Ta Huang, Chiu Lan Hsieh, Robert Y. Peng

研究成果: 雜誌貢獻文章

20 引文 (Scopus)

摘要

Aqueous extract of Psidium guajava L. budding leaves (PE) has been shown to possess anti-prostate cancer activity in a cell line model. We examined whether its bioactivity could be conserved either in the presence or the absence of synthetic androgen R1881. In both cases, PE was shown to inhibit LNCaP cell proliferation and down-regulate expressions of androgen receptor (AR) and prostate specific antigen (PSA). The cytotoxicity of PE was shown by enhanced LDH release in LNCaP cells. The flow cytometry analysis revealed cell cycle arrests at G0/G1 phase with huge amount of apoptotic LNCaP cells after treatment with PE for 48 h in a dose-responsive manner, which was also confirmed by TUNEL assay. From the results of decreased Bcl-2/Bax ratio, inactivation of phosphor-Akt, activation of phosphor-p38, phospho-Erk1/phospho- Erk2, the molecular action mechanism of PE to induce apoptosis in LNCaP cells was elucidated. Compatible with the in vitro study findings, treatment with PE (1.5 mg/mouse/day) significantly diminished both the PSA serum levels and tumor size in a xenograft mouse tumor model. Conclusively, PE is a promising anti-androgen-sensative prostate cancer agent.
原文英語
頁(從 - 到)260-270
頁數11
期刊Nutrition and Cancer
62
發行號2
DOIs
出版狀態已發佈 - 二月 2010

指紋

Psidium
Signal Transduction
Prostatic Neoplasms
Prostate-Specific Antigen
Testosterone Congeners
Metribolone
Cell Cycle Resting Phase
In Situ Nick-End Labeling
G1 Phase
Androgen Receptors
Cell Cycle Checkpoints
Heterografts
Androgens
Neoplasms
Flow Cytometry
Down-Regulation
Cell Proliferation
Apoptosis
Cell Line
Serum

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Oncology
  • Cancer Research

引用此文

Action mechanism and signal pathways of psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells. / Chen, Kuan Chou; Peng, Chiung Chi; Chiu, Wen Ta; Cheng, Yu Ting; Huang, Guan Ta; Hsieh, Chiu Lan; Peng, Robert Y.

於: Nutrition and Cancer, 卷 62, 編號 2, 02.2010, p. 260-270.

研究成果: 雜誌貢獻文章

Chen, Kuan Chou ; Peng, Chiung Chi ; Chiu, Wen Ta ; Cheng, Yu Ting ; Huang, Guan Ta ; Hsieh, Chiu Lan ; Peng, Robert Y. / Action mechanism and signal pathways of psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells. 於: Nutrition and Cancer. 2010 ; 卷 62, 編號 2. 頁 260-270.
@article{d6921fea37ee4399b5cecbdc3fb0e988,
title = "Action mechanism and signal pathways of psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells",
abstract = "Aqueous extract of Psidium guajava L. budding leaves (PE) has been shown to possess anti-prostate cancer activity in a cell line model. We examined whether its bioactivity could be conserved either in the presence or the absence of synthetic androgen R1881. In both cases, PE was shown to inhibit LNCaP cell proliferation and down-regulate expressions of androgen receptor (AR) and prostate specific antigen (PSA). The cytotoxicity of PE was shown by enhanced LDH release in LNCaP cells. The flow cytometry analysis revealed cell cycle arrests at G0/G1 phase with huge amount of apoptotic LNCaP cells after treatment with PE for 48 h in a dose-responsive manner, which was also confirmed by TUNEL assay. From the results of decreased Bcl-2/Bax ratio, inactivation of phosphor-Akt, activation of phosphor-p38, phospho-Erk1/phospho- Erk2, the molecular action mechanism of PE to induce apoptosis in LNCaP cells was elucidated. Compatible with the in vitro study findings, treatment with PE (1.5 mg/mouse/day) significantly diminished both the PSA serum levels and tumor size in a xenograft mouse tumor model. Conclusively, PE is a promising anti-androgen-sensative prostate cancer agent.",
author = "Chen, {Kuan Chou} and Peng, {Chiung Chi} and Chiu, {Wen Ta} and Cheng, {Yu Ting} and Huang, {Guan Ta} and Hsieh, {Chiu Lan} and Peng, {Robert Y.}",
year = "2010",
month = "2",
doi = "10.1080/01635580903407130",
language = "English",
volume = "62",
pages = "260--270",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Action mechanism and signal pathways of psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells

AU - Chen, Kuan Chou

AU - Peng, Chiung Chi

AU - Chiu, Wen Ta

AU - Cheng, Yu Ting

AU - Huang, Guan Ta

AU - Hsieh, Chiu Lan

AU - Peng, Robert Y.

PY - 2010/2

Y1 - 2010/2

N2 - Aqueous extract of Psidium guajava L. budding leaves (PE) has been shown to possess anti-prostate cancer activity in a cell line model. We examined whether its bioactivity could be conserved either in the presence or the absence of synthetic androgen R1881. In both cases, PE was shown to inhibit LNCaP cell proliferation and down-regulate expressions of androgen receptor (AR) and prostate specific antigen (PSA). The cytotoxicity of PE was shown by enhanced LDH release in LNCaP cells. The flow cytometry analysis revealed cell cycle arrests at G0/G1 phase with huge amount of apoptotic LNCaP cells after treatment with PE for 48 h in a dose-responsive manner, which was also confirmed by TUNEL assay. From the results of decreased Bcl-2/Bax ratio, inactivation of phosphor-Akt, activation of phosphor-p38, phospho-Erk1/phospho- Erk2, the molecular action mechanism of PE to induce apoptosis in LNCaP cells was elucidated. Compatible with the in vitro study findings, treatment with PE (1.5 mg/mouse/day) significantly diminished both the PSA serum levels and tumor size in a xenograft mouse tumor model. Conclusively, PE is a promising anti-androgen-sensative prostate cancer agent.

AB - Aqueous extract of Psidium guajava L. budding leaves (PE) has been shown to possess anti-prostate cancer activity in a cell line model. We examined whether its bioactivity could be conserved either in the presence or the absence of synthetic androgen R1881. In both cases, PE was shown to inhibit LNCaP cell proliferation and down-regulate expressions of androgen receptor (AR) and prostate specific antigen (PSA). The cytotoxicity of PE was shown by enhanced LDH release in LNCaP cells. The flow cytometry analysis revealed cell cycle arrests at G0/G1 phase with huge amount of apoptotic LNCaP cells after treatment with PE for 48 h in a dose-responsive manner, which was also confirmed by TUNEL assay. From the results of decreased Bcl-2/Bax ratio, inactivation of phosphor-Akt, activation of phosphor-p38, phospho-Erk1/phospho- Erk2, the molecular action mechanism of PE to induce apoptosis in LNCaP cells was elucidated. Compatible with the in vitro study findings, treatment with PE (1.5 mg/mouse/day) significantly diminished both the PSA serum levels and tumor size in a xenograft mouse tumor model. Conclusively, PE is a promising anti-androgen-sensative prostate cancer agent.

UR - http://www.scopus.com/inward/record.url?scp=76749137291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749137291&partnerID=8YFLogxK

U2 - 10.1080/01635580903407130

DO - 10.1080/01635580903407130

M3 - Article

C2 - 20099201

AN - SCOPUS:76749137291

VL - 62

SP - 260

EP - 270

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 2

ER -